HPGC Renmintongtai Pharmaceutical Corporation (600829.SS)

CNY 7.3

(1.53%)

Total Liabilities Summary of HPGC Renmintongtai Pharmaceutical Corporation

  • HPGC Renmintongtai Pharmaceutical Corporation's latest annual total liabilities in 2023 was 4.55 Billion CNY , down -0.91% from previous year.
  • HPGC Renmintongtai Pharmaceutical Corporation's latest quarterly total liabilities in 2024 Q3 was 4.15 Billion CNY , down -2.57% from previous quarter.
  • HPGC Renmintongtai Pharmaceutical Corporation reported annual total liabilities of 4.59 Billion CNY in 2022, up 1.04% from previous year.
  • HPGC Renmintongtai Pharmaceutical Corporation reported annual total liabilities of 4.54 Billion CNY in 2021, up 13.64% from previous year.
  • HPGC Renmintongtai Pharmaceutical Corporation reported quarterly total liabilities of 4.15 Billion CNY for 2024 Q3, down -2.57% from previous quarter.
  • HPGC Renmintongtai Pharmaceutical Corporation reported quarterly total liabilities of 4.26 Billion CNY for 2024 Q2, down -5.67% from previous quarter.

Annual Total Liabilities Chart of HPGC Renmintongtai Pharmaceutical Corporation (2023 - 1994)

Historical Annual Total Liabilities of HPGC Renmintongtai Pharmaceutical Corporation (2023 - 1994)

Year Total Liabilities Total Liabilities Growth
2023 4.55 Billion CNY -0.91%
2022 4.59 Billion CNY 1.04%
2021 4.54 Billion CNY 13.64%
2020 4 Billion CNY 8.18%
2019 3.7 Billion CNY 30.63%
2018 2.83 Billion CNY -12.29%
2017 3.22 Billion CNY 2.12%
2016 3.16 Billion CNY 12.57%
2015 2.8 Billion CNY 148.89%
2014 1.12 Billion CNY -21.82%
2013 1.44 Billion CNY -17.3%
2012 1.74 Billion CNY -8.51%
2011 1.9 Billion CNY 20.6%
2010 1.58 Billion CNY 32.2%
2009 1.19 Billion CNY -5.44%
2008 1.26 Billion CNY -0.69%
2007 1.27 Billion CNY 10.25%
2006 1.15 Billion CNY 5.01%
2005 1.1 Billion CNY 32.94%
2004 828.08 Million CNY 60.34%
2003 516.45 Million CNY 27.93%
2002 403.71 Million CNY -12.16%
2001 459.58 Million CNY -14.05%
2000 534.73 Million CNY 85.96%
1999 287.55 Million CNY 18.95%
1998 241.75 Million CNY 0.12%
1997 241.46 Million CNY 3.91%
1996 232.36 Million CNY 3.57%
1995 224.35 Million CNY 11.75%
1994 200.76 Million CNY 0.0%

Peer Total Liabilities Comparison of HPGC Renmintongtai Pharmaceutical Corporation

Name Total Liabilities Total Liabilities Difference
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.38 Billion CNY -34.374%
Yabao Pharmaceutical Group Co., Ltd 860.33 Million CNY -429.348%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.65 Billion CNY -175.987%
Tasly Pharmaceutical Group Co., Ltd 3.86 Billion CNY -17.823%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 1.6 Billion CNY -183.097%
Hubei Jumpcan Pharmaceutical Co., Ltd. 4.7 Billion CNY 3.156%
Shandong Lukang Pharmaceutical Co.,Ltd. 4.95 Billion CNY 7.999%
North China Pharmaceutical Company Ltd. 14.68 Billion CNY 68.989%
Zhejiang Shengda Bio-Pharm Co., Ltd. 449.19 Million CNY -913.845%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 4.42 Billion CNY -2.913%
Dali Pharmaceuticalco.,Ltd 92.7 Million CNY -4812.31%
Guobang Pharma Ltd. 2.92 Billion CNY -55.727%
ChengDu ShengNuo Biotec Co.,Ltd. 431.06 Million CNY -956.476%
Changchun BCHT Biotechnology Co. 1.01 Billion CNY -348.234%
China Animal Husbandry Industry Co., Ltd. 2.38 Billion CNY -91.076%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 2.24 Billion CNY -102.931%
Kangmei Pharmaceutical Co., Ltd. 7.19 Billion CNY 36.747%
Zhejiang Starry Pharmaceutical Co.,Ltd. 3.66 Billion CNY -24.149%
Shandong Buchang Pharmaceuticals Co., Ltd. 9.2 Billion CNY 50.52%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.6 Billion CNY -183.921%
Zhejiang Huahai Pharmaceutical Co., Ltd. 10.34 Billion CNY 55.994%
Harbin Pharmaceutical Group Co., Ltd. 8.37 Billion CNY 45.591%
Zhejiang Medicine Co., Ltd. 2.79 Billion CNY -63.047%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 3.49 Billion CNY -30.41%
Lionco Pharmaceutical Group Co.,Ltd. 693.51 Million CNY -556.673%
Humanwell Healthcare (Group) Co.,Ltd. 15.38 Billion CNY 70.404%
Ginwa Enterprise (Group) Inc. 470.12 Million CNY -868.71%
KPC Pharmaceuticals, Inc. 3.9 Billion CNY -16.616%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 440.92 Million CNY -932.867%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 299.24 Million CNY -1421.856%
Ningbo Menovo Pharmaceutical Co., Ltd. 2.23 Billion CNY -103.507%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 2.2 Billion CNY -106.089%
Nanjing Well Pharmaceutical Group Co.,Ltd. 686.22 Million CNY -563.655%
Henan Lingrui Pharmaceutical Co., Ltd. 1.97 Billion CNY -130.798%
Joincare Pharmaceutical Group Industry Co.,Ltd. 13.34 Billion CNY 65.883%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 3.52 Billion CNY -29.156%
Chongqing Taiji Industry(Group) Co.,Ltd 10.52 Billion CNY 56.734%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 40.9 Billion CNY 88.867%
China National Medicines Corporation Ltd. 14.87 Billion CNY 69.382%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.54 Billion CNY -195.707%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.47 Billion CNY -209.241%
Zhongzhu Healthcare Holding Co.,Ltd 422.34 Million CNY -978.308%
Beijing Tongrentang Co., Ltd 9.67 Billion CNY 52.928%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 515.97 Million CNY -782.635%
Jianmin Pharmaceutical Group Co.,Ltd. 1.89 Billion CNY -140.596%
Tibet Weixinkang Medicine Co., Ltd. 436.54 Million CNY -943.218%
CanSino Biologics Inc. 3.86 Billion CNY -17.816%
Zhejiang Hisun Pharmaceutical Co., Ltd. 9.26 Billion CNY 50.84%
Shanghai Jiaoda Onlly Co.,Ltd 475.91 Million CNY -856.922%
Jiang Zhong Pharmaceutical Co.,Ltd 1.6 Billion CNY -183.836%
Mayinglong Pharmaceutical Group Co., LTD. 959.61 Million CNY -374.579%
Cisen Pharmaceutical Co., Ltd. 1.57 Billion CNY -189.818%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 696.15 Million CNY -554.186%
Hunan Warrant Pharmaceutical Co.,Ltd 358.76 Million CNY -1169.394%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 56.77 Billion CNY 91.979%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.49 Billion CNY -205.184%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 1.03 Billion CNY -341.377%
Henan Taloph Pharmaceutical Stock Co.,Ltd 1.95 Billion CNY -133.521%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.64 Billion CNY -24.798%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 805.75 Million CNY -465.199%
Shanghai Shyndec Pharmaceutical Co., Ltd. 4.89 Billion CNY 6.892%
Shanghai Yizhong Pharmaceutical Co., Ltd. 107.05 Million CNY -4154.095%
Tibet Rhodiola Pharmaceutical Holding Co. 1.18 Billion CNY -283.384%
Sichuan Huiyu Pharmaceutical Co., Ltd. 886.91 Million CNY -413.48%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 1.33 Billion CNY -240.27%